TGA Approval

BORTRACZO bortezomib 3.5 mg/1.4 mL solution for injection vial (444812)

ARTG ID

444812

ARTG Name

BORTRACZO bortezomib 3.5 mg/1.4 mL solution for injection vial

Sponsor

Glenmark Pharmaceuticals Australia Pty Ltd

ARTG Date

May 22, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GLENMARK PHARMACEUTICALS (AUSTRALIA) PTY LIMITED

Ingredient Name

bortezomib

Empowering clinical research with data-driven insights and AI-powered tools.

BORTRACZO bortezomib 3.5 mg/1.4 mL solution for injection vial (444812) - TGA 批准文号 | MedPath